December 20, 2016 / 1:27 PM / 7 months ago

BRIEF-X-Chem announces multi-target drug discovery collaboration with Taiho Pharmaceutical using DEX technology

1 Min Read

Dec 20 (Reuters) - Otsuka Holdings Co Ltd :

* X-Chem Inc- announces multi-target drug discovery collaboration with Taiho pharmaceutical using DEX technology

* X-Chem - will receive up-front payment as well as potential pre-clinical, clinical, regulatory milestone payments, sales milestones, up to total of $352 million

* X-Chem Inc - Taiho has an exclusive option to license any programs generated in course of collaboration

* X-Chem Inc-will also receive royalties for each successfully commercialized drug that results from a licensed collaboration program Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below